Our understanding of autism has changed significantly in the past years. Previously viewed as a rare childhood disorder with a focus on deficits and pathology, autism is now recognized as a common, lifelong and heterogenous ...
Sep 17, 2024
0
0
Vaping may look cool when you're young, but it appears to be dulling the brains of college students, a new study warns.
Sep 16, 2024
0
6
Professors Tom Powles and Peter Schmid recently delivered results from their phase three clinical trials during Sunday's Presidential Symposium to over 30,000 attendees at the European Society for Medical Oncology (ESMO) ...
Sep 16, 2024
0
0
Scientists have pinpointed thousands of genetic changes in a gene that may increase a person's risk of developing breast and ovarian cancer, paving the way for better risk assessment and more personalized care.
Sep 18, 2024
0
16
While the link between diabetes and periodontal disease is known, the impact of diabetes treatment on periodontal health is less well understood. Research published in Diabetes, Obesity and Metabolism demonstrates that periodontal ...
Sep 17, 2024
0
5
Pregnancy is a transformative time in a person's life where the body undergoes rapid physiological adaptations to prepare for motherhood—that we all know. What has remained something of a mystery is what the sweeping hormonal ...
Sep 16, 2024
0
26
New therapeutic opportunities often emerge from research on simple organisms. For instance, the 2020 Nobel Prize in Chemistry awarded to Emmanuelle Charpentier, Ph.D., and Jennifer Doudna, Ph.D., for their CRISPR-based DNA ...
Sep 18, 2024
0
14
The antibody-drug conjugate (ADC) puxitatug samrotecan (AZD8205) demonstrated a manageable safety profile consistent with similar ADCs and initial efficacy in heavily pretreated patients with advanced or metastatic solid ...
Sep 13, 2024
0
0
The RESILIENCE clinical trial has been designed to explore the effectiveness and safety of remote ischemic conditioning (RIC) used to prevent the cardiotoxic effects of anthracycline-based chemotherapy in patients with lymphoma.
Sep 16, 2024
0
0
New evidence shows that extended estrogen suppression treatment using aromatase inhibitors for hormone receptor-positive postmenopausal breast cancer is safe; it does not increase the risk of coronary artery calcification, ...
Sep 17, 2024
0
0
